NeuroBo Pharmaceuticals (NRBO)
US Market

NeuroBo Pharmaceuticals (NRBO) Stock Price & Analysis


NRBO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.89 - $7.59
Previous Close$3.97
Average Volume (3M)1.37M
Market Cap
Enterprise Value-$9.22M
Total Cash (Recent Filing)$28.70M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.6
Aug 13, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.46
Shares Outstanding4,906,032
10 Day Avg. Volume35,120
30 Day Avg. Volume1,369,062
Standard Deviation0.25
Financial Highlights & Ratios
Price to Book (P/B)0.88
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda1.13
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.


What was NeuroBo Pharmaceuticals’s price range in the past 12 months?
NeuroBo Pharmaceuticals lowest stock price was $2.89 and its highest was $7.59 in the past 12 months.
    What is NeuroBo Pharmaceuticals’s market cap?
    Currently, no data Available
    When is NeuroBo Pharmaceuticals’s upcoming earnings report date?
    NeuroBo Pharmaceuticals’s upcoming earnings report date is Aug 13, 2024 which is in 121 days.
      How were NeuroBo Pharmaceuticals’s earnings last quarter?
      NeuroBo Pharmaceuticals released its earnings results on Mar 28, 2024. The company reported -$0.785 earnings per share for the quarter, the consensus estimate of -$0.785 by $0.
        Is NeuroBo Pharmaceuticals overvalued?
        According to Wall Street analysts NeuroBo Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does NeuroBo Pharmaceuticals pay dividends?
          NeuroBo Pharmaceuticals does not currently pay dividends.
          What is NeuroBo Pharmaceuticals’s EPS estimate?
          NeuroBo Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does NeuroBo Pharmaceuticals have?
          NeuroBo Pharmaceuticals has 4,906,032 shares outstanding.
            What happened to NeuroBo Pharmaceuticals’s price movement after its last earnings report?
            NeuroBo Pharmaceuticals reported an EPS of -$0.785 in its last earnings report, expectations of -$0.785. Following the earnings report the stock price went down -5.76%.
              Which hedge fund is a major shareholder of NeuroBo Pharmaceuticals?
              Currently, no hedge funds are holding shares in NRBO

              NeuroBo Pharmaceuticals Stock Smart Score

              Company Description

              NeuroBo Pharmaceuticals

              NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.
              Similar Stocks
              Price & Change
              Crinetics Pharmaceuticals
              Kura Oncology
              Bioxcel Therapeutics
              Popular Stocks
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis